Business Standard

Sun Pharma gains on acquisition of URL generic biz

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco.

Related News

Sun Pharmaceutical Industries is trading higher by 2% at Rs 732 after the company said it has buys generic business of pharma through its subsidiary for an undisclosed amount.

“Caraco Pharmaceutical Laboratories, wholly-owned subsidiary of the company, has entered into a definitive agreement with Pharmaceuticals U.S.A., Inc, a wholly-owned subsidiary of Takeda Pharmaceutical Company, to buy the URL Pharma, Inc. generic business,” said in a statement.

Upon completion of the purchase, the non-colcrys generic assets of URL Pharma will be owned and managed by Caraco. The deal is subject to satisfaction of customary closing conditions, including applicable regulatory approvals, it added.

The stock opened at Rs 727 and hit a high of Rs 733 on the NSE. A combined 138,547 shares have changed hands on the counter in morning deals.

Read more on:   
|
|

Read More

Two entities fail to make prima facie case to revoke ban: Sebi

The Securities and Exchange Board of India (Sebi) today said the restraining order on two entities, related to plunge in some mid-cap stocks in July, ...

Quick Links

 

Market News

Refined soya oil up 0.8% on spot demand

Oil for delivery in December edged higher by 0.49%

Cardamom up 2% on rising demand

Spice for delivery in December gained 0.59%

Nifty holds 7,900, Oil shares slip, ONGC down 2%

The 30-share Sensex is up 129 points at 26,559 and the 50-share Nifty has gained 38 points to trade at 7,918.

Palm oil up 0.6% on spot demand

Oil for delivery in November traded higher by 0.57%

Nickel down 0.1% on global cues

Metal for delivery in October traded lower by 0.04%

Back to Top